FrancophonIA/ELRC3.0 huggingface dataset:
English: • axial spondyloarthritis (inflammation of spine causing back pain), including ankylosing spondylitis and when there is no damage on X-ray but clear signs of inflammation
Croatian: • aksijalnog spondiloartritisa (upale kralježnice koja uzrokuje bolove u leđima), kao i ankilozantnog spondilitisa te kad rendgenska snimka ne pokazuje oštećenja, nego jasne znakove upale
English: What benefits of Solymbic have been shown in studies?
Croatian: Koje su koristi lijeka Solymbic dokazane u ispitivanjima?
English: How does Solymbic work?
Croatian: Kako djeluje Solymbic?
English: For more information about treatment with Solymbic, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Solymbic pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: For practical information about using Solymbic, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Solymbic bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: How is Solymbic used?
Croatian: Kako se Solymbic koristi?
English: For information on the doses to be used for each condition and other information on the use of Solymbic, see the package leaflet.
Croatian: Informacije o doziranju za svako od navedenih stanja i druge informacije o primjeni lijeka Solymbic pročitajte u uputi o lijeku.
English: The medicine has been shown to have similar effects to Humira in one main study involving 526 patients with moderate to severe rheumatoid arthritis that had not responded adequately to methotrexate, and in another study in 350 patients with moderate to severe psoriasis.
Croatian: U glavnom ispitivanju u kojemu je sudjelovalo 526 bolesnika s umjerenim do teškim reumatoidnim artritisom, koji nisu imali prikladan klinički odgovor na metotreksat, kao i u još jednom ispitivanju u kojemu je sudjelovalo 350 bolesnika s umjerenom do teškom psorijazom utvrđeno je da taj lijek djeluje slično lijeku Humira.
English: For the full list of restrictions with Solymbic, see the package leaflet.
Croatian: Potpuni popis ograničenja lijeka Solymbic potražite u uputi o lijeku.
English: • active enthesitis-related arthritis (a rare disease causing inflammation in the joints)
Croatian: • aktivnog reumatoidnog artritisa povezanog s entezitisom (rijetke bolesti koja uzrokuje upalu zglobova)
English: For detailed information on the use of Solymbic in all conditions, including when it can be used in children, see the summary of product characteristics (also part of the EPAR).
Croatian: Detaljne informacije o primjeni lijeka Solymbic za sva stanja potražite u sažetku opisa svojstva lijeka (također dio EPAR-a).
English: 400 mg / 100 mg / 100 mg Film-coated tablet Oral use bottle (HDPE)
Croatian: 400 mg / 100 mg / 100 mg
English: Karvea should not be given to children under 18 years of age.
Croatian: Karvea se ne smije davati djeci mlađoj od 18 godina.
English: It is important that you continue to take Karvea until your doctor tells you otherwise.
Croatian: Važno je da nastavite uzimati lijek Karvea sve dok Vam liječnik ne kaže drukčije.
English: The safety and efficacy of Karvea in children aged 0 to 18 has not been established.
Croatian: Sigurnost i djelotvornost lijeka Karvea u djece u dobi od 0 do 18 godina nisu ustanovljene.
English: What Karvea is and what it is used for
Croatian: Što je Karvea i za što se koristi
English: See also information under the heading “Do not take Karvea”.
Croatian: Vidjeti također informacije pod naslovom „Nemojte uzimati lijek Karvea“.
English: Karvea with food and drink Karvea can be taken with or without food.
Croatian: Karvea s hranom i pićem Karvea se može uzeti s hranom ili bez nje.
English: Other medicines and Karvea
Croatian: Drugi lijekovi i Karvea
English: If you take more Karvea than you should
Croatian: Ako uzmete više lijeka Karvea nego što se trebali
English: Please see section 2 “Karvea contains lactose”.
Croatian: Vidjeti dio 2., „Karvea sadrži laktozu“
English: You can take Karvea with or without food.
Croatian: Karvea se može uzimati s hranom ili bez nje.
English: Karvea contains lactose.
Croatian: Karvea sadrži laktozu.
English: No specific information is available on the treatment of overdose with Karvea.
Croatian: Nema dostupnih specifičnih podataka o liječenju predoziranja lijekom Karvea.
English: Your doctor will normally advise you to stop taking Karvea before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Karvea.
Croatian: Vaš će Vam liječnik obično preporučiti da prestanete uzimati lijek Karvea prije nego što zatrudnite ili čim saznate da ste trudni te će Vam savjetovati da uzmete neki drugi lijek umjesto lijeka Karvea.
English: IDNT was a double blind, controlled, morbidity and mortality trial comparing Karvea, amlodipine and placebo.
Croatian: IDNT je bilo dvostruko slijepo, kontrolirano ispitivanje morbiditeta i mortaliteta u kojem su uspoređivani Karvea, amlodipin i placebo.
English: If you get any of these symptoms or get short of breath, stop taking Karvea and contact your doctor immediately.
Croatian: Ako primijetite bilo koji od ovih simptoma ili osjetite nedostatak zraka, prestanite uzimati lijek Karvea i odmah se javite liječniku.
English: Karvea is indicated in adults for the treatment of essential hypertension.
Croatian: Karvea je indicirana za liječenje esencijalne hipertenzije u odraslih.
English: Therefore, the use of Karvea is not recommended.
Croatian: Stoga se ne preporučuje primjena lijeka Karvea.
English: What Karvea is and what it is used for What you need to know before you take Karvea How to take Karvea
Croatian: Što je Karvea i za što se koristi Što morate znati prije nego počnete uzimati lijek Karvea Kako uzimati lijek Karvea
English: Some undesirable effects have been reported since marketing of Karvea.
Croatian: Neke nuspojave prijavljene su otkad je Karvea na tržištu.
English: What you need to know before you take Karvea
Croatian: Što morate znati prije nego počnete uzimati lijek Karvea
English: Karvea is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
Croatian: Karvea se ne preporučuje majkama koje doje, a Vaš liječnik može izabrati drugu terapiju ako želite dojiti, osobito ako se radi o dojenju novorođenčeta ili nedonoščeta.
English: Karvea at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.
Croatian: Doza od 150 mg lijeka Karvea jedanput na dan općenito osigurava bolju kontrolu krvnog tlaka u razdoblju od 24 sata nego doza od 75 mg.
English: Irbesartan AUC and Cmax values were also somewhat greater in older subjects (≥ 65 years) than those of young subjects (18 - 40 years).
Croatian: Vrijednosti AUC i Cmax irbesartana također su bile nešto veće u starijih ispitanika (≥ 65 godina) u usporedbi s mlađima (18-40 godina).
English: Karvea belongs to a group of medicines known as angiotensin-II receptor antagonists.
Croatian: Karvea pripada skupini lijekova koja se naziva antagonisti receptora angiotenzina II.
English: Such conditions should be corrected before the administration of Karvea.
Croatian: Takva stanja treba korigirati prije primjene lijeka Karvea.
English: Karvea is unlikely to affect your ability to drive or use machines.
Croatian: Karvea ne bi trebala utjecati na Vašu sposobnost upravljanja vozilima i strojevima.
English: Regression to normoalbuminuria (< 30 mg/day) was more frequent in the Karvea 300 mg group (34%) than in the placebo group (21%).
Croatian: Regresija do normoalbuminurije (< 30 mg/dan) bila je češća u skupini koja je primala lijek Karvea u dozi od 300 mg (34%) nego u skupini koja je primala placebo (21%).
English: Patients were titrated from 75 mg to a maintenance dose of 300 mg Karvea, from 2.5 mg to 10 mg amlodipine, or placebo as tolerated.
Croatian: Bolesnici su titrirani od 75 mg do doze održavanja od 300 mg lijeka Karvea, od 2,5 mg do 10 mg amlodipina ili placeba do granice podnošljivosti.
English: In particular, the addition of a diuretic such as hydrochlorothiazide has been shown to have an additive effect with Karvea (see section 4.5).
Croatian: Pokazalo se da dodavanje diuretika poput hidroklorotiazida ostvaruje aditivan učinak s lijekom Karvea (vidjeti dio 4.5).
English: There is no experience regarding the administration of Karvea in patients with a recent kidney transplantation.
Croatian: Nema iskustava s primjenom lijeka Karvea u bolesnika kojima je nedavno transplantiran bubreg.
English: Irbesartan significantly reduced the relative risk in the primary combined endpoint of doubling serum creatinine, end-stage renal disease (ESRD) or all cause mortality.
Croatian: Irbesartan značajno snižava relativni rizik u primarnoj kombiniranoj mjeri ishoda udvostručavanja serumskog kreatinina, terminalne faze bubrežne bolesti ili svih uzroka mortaliteta.
English: If you forget to take Karvea
Croatian: Ako ste zaboravili uzeti lijek Karvea
English: Prior treatment with high dose diuretics may result in volume depletion and a risk of hypotension when initiating therapy with Karvea (see section 4.4).
Croatian: Prethodno liječenje visokim dozama diuretika može dovesti do smanjenja volumena i rizika od pojave hipotenzije prilikom uvođenja terapije lijekom Karvea (vidjeti dio 4.4).
English: Renal impairment and kidney transplantation: when Karvea is used in patients with impaired renal function, a periodic monitoring of potassium and creatinine serum levels is recommended.
Croatian: Oštećena funkcija bubrega i transplantacija bubrega: kad lijek Karvea uzimaju bolesnici s oštećenom funkcijom bubrega, preporučuje se periodički kontrolirati serumske razine kalija i kreatinina.
English: Karvea is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Croatian: Karvea se ne preporučuje u ranoj trudnoći te se ne smije uzimati nakon trećeg mjeseca trudnoće jer može ozbiljno naškoditi Vašem djetetu ako je uzimate u tom razdoblju.
English: Because no information is available regarding the use of Karvea during breast-feeding, Karvea is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Croatian: Budući da nema dostupnih podataka o upotrebi lijeka Karvea tijekom dojenja, ne preporučuje se njegova primjena tijekom dojenja i prednost treba dati drugoj terapiji s ustanovljenim boljim profilom sigurnosti primjene, osobito kada se doji novorođenče ili nedonošče.
English: The blood pressure lowering effect of Karvea is evident within 1-2 weeks, with the maximal effect occurring by 4-6 weeks after start of therapy.
Croatian: Učinak lijeka Karvea na snižavanje krvnog tlaka vidljiv je unutar 1-2 tjedna, s maksimalnim učinkom nakon 4-6 tjedana od početka terapije.
English: How to take Karvea
Croatian: Kako uzimati Karvea
English: Karvea prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower.
Croatian: Karvea sprječava vezanje angiotenzina II na te receptore uzrokujući opuštanje krvnih žila i sniženje krvnog tlaka.
English: Lithium: the combination of lithium and Karvea is not recommended (see section 4.5).
Croatian: Litij: ne preporučuje se kombinacija litija i lijeka Karvea (vidjeti dio 4.5).
English: In patients insufficiently controlled with 150 mg once daily, the dose of Karvea can be increased to 300 mg, or other antihypertensive agents can be added (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: U bolesnika u kojih se bolest ne može dostatno kontrolirati dozom od 150 mg jedanput na dan, doza lijeka Karvea može se povećati na 300 mg ili se mogu dodati drugi antihipertenzivi (vidjeti dijelove 4.3, 4.4, 4.5 i 5.1).
English: While this is not documented with Karvea, a similar effect should be anticipated with angiotensin-II receptor antagonists.
Croatian: Iako to još nije potvrđeno za lijek Karvea, sličan učinak može se očekivati s antagonistima receptora angiotenzina II.
English: Karvea is used in adult patients to treat high blood pressure (essential hypertension) to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.
Croatian: Karvea se primjenjuje u odraslih bolesnika za liječenje visokog krvnog tlaka (esencijalne hipertenzije) zaštitu bubrega u bolesnika sa šećernom bolešću tipa 2 koji imaju povišeni krvni tlak i laboratorijski dokazanu oslabljenu bubrežnu funkciju.
English: In 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/day and serum creatinine ranging from 1.0-3.0 mg/dl, the long-term effects (mean 2.6 years) of Karvea on the progression of renal disease and all-cause mortality were examined.
Croatian: U 1715 hipertenzivnih bolesnika sa šećernom bolešću tipa 2, proteinurijom ≥ 900 mg/dan i serumskim kreatininom u rasponu od 1,0 do 3,0 mg/dl ispitivan je dugotrajan učinak lijeka Karvea (prosječno 2,6 godina) na progresiju bubrežne bolesti i svih uzroka mortaliteta.
English: hypersensitivity reactions such as angioedema, rash, urticaria, anaphylactic reaction, anaphylactic shock
Croatian: reakcije preosjetljivosti kao što su angioedem, osip, urtikarija, anafilaktička reakcija, anafilaktički šok Poremećaji metabolizma i prehrane Nepoznato:
English: Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Karvea, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Croatian: Hiperkalijemija: kao i kod ostalih lijekova koji djeluju na renin-angiotenzin-aldosteronski sustav, tijekom liječenja lijekom Karvea može se pojaviti hiperkalijemija, posebice ako je prisutna oštećena bubrežna funkcija, izražena proteinurija zbog dijabetičke bubrežne bolesti i/ili zatajenje srca.
English: The study examined the long-term effects (2 years) of Karvea on the progression to clinical (overt) proteinuria (urinary albumin excretion rate (UAER) > 300 mg/day, and an increase in UAER of at least 30% from baseline).
Croatian: U ispitivanju su ispitivani dugotrajni učinci (2 godine) lijeka Karvea na progresiju klinički izražene proteinurije (brzina izlučivanja albumina u mokraću > 300 mg/dan i porast u vrijednostima brzine izlučivanja albumina u mokraću od najmanje 30% u odnosu na početne vrijednosti).
English: In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics if you are taking any of the following medicines used to treat high blood pressure: o an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
Croatian: U tom će Vam slučaju Vaš liječnik možda raditi redovite pretrage krvi, posebno određivanje koncentracije kalija u krvi u slučaju oslabljene funkcije bubrega ako trebate ići na bilo kakav kirurški zahvat ili trebate primiti anestetike ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka: ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću. aliskiren Liječnik Vam može provjeravati bubrežnu funkciju, krvni tlak i količinu elektrolita (npr. kalija) u krvi u redovitim intervalima.
English: Over a subsequent two week period where patients were re-randomized to either active medicinal product or placebo, patients on placebo had increases of 2.4 and 2.0 mmHg in SeSBP and SeDBP compared to +0.1 and -0.3 mmHg changes respectively in those on all doses of irbesartan (see section 4.2).
Croatian: Tijekom sljedeća dva tjedna kada su bolesnici ponovo randomizirani ili na lijek ili na placebo, bolesnici na placebu imali su porast od 2,4 i 2,0 mmHg za SjSKT i SjDKT,u usporedbi s promjenom od +0,1 i -0,3 mmHg u bolesnika na svim dozama irbesartana (vidjeti dio 4.2).
English: NAME OF THE MARKETING AUTHORISATION HOLDER sanofi-aventis groupe
Croatian: Nositelj odobrenja za stavljanje lijeka u promet: sanofi-aventis groupe
English: Karvea slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.
Croatian: Karvea usporava slabljenje bubrežne funkcije u bolesnika koji imaju povišen krvni tlak i boluju od šećerne bolesti tipa 2.
English: The concomitant use of Karvea with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (glomerular filtration rate (GFR) <60 ml/min/1.73m2) (see sections 4.5 and 5.1).
Croatian: Istodobna primjena lijeka Karvea s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrega (GFR < 60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
English: The demonstration of renal benefit of Karvea in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: Dokaz koristi lijeka Karvea na bubrežnu funkciju u hipertenzivnih bolesnika sa šećernom bolešću tipa 2 zasniva se na ispitivanjima u kojima se irbesartan prema potrebi uzimao kao dopuna ostaloj antihipertenzivnoj terapiji za postizanje ciljnog krvnog tlaka (vidjeti dijelove 4.3, 4.4, 4.5 i 5.1).
English: Karvea is for oral use.
Croatian: Karvea je namijenjena za primjenu kroz usta.
English: Karvea is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Croatian: Ne smijete je uzimati nakon trećeg mjeseca trudnoće jer može ozbiljno naškoditi Vašem djetetu ako je uzimate u tom stadiju (vidjeti dio o trudnoći).
English: Each tablet of Karvea 75 mg contains 75 mg irbesartan.
Croatian: Jedna Karvea 75 mg tableta sadrži 75 mg irbesartana.
English: If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Karvea” and “Warnings and precautions”).
Croatian: “Nemojte uzimati lijek Karvea” i “Upozorenja i mjere opreza”).
English: Warning and precautions Talk to your doctor before taking Karvea and if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems if you suffer from heart problems if you receive Karvea for diabetic kidney disease.
Croatian: Obratite se svom liječniku prije nego uzmete lijek Karvea ako se nešto od dolje navedenog odnosi na Vas: ako Vas muči prekomjerno povraćanje ili proljev ako imate problema s bubrezima ako imate srčanih problema ako uzimate lijek Karvea zbog dijabetičke bolesti bubrega.
English: Each tablet of Karvea 150 mg contains 150 mg irbesartan.
Croatian: Jedna Karvea 150 mg tableta sadrži 150 mg irbesartana.
English: The efficacy of Karvea is not influenced by age or gender.
Croatian: Dob i spol ne utječu na djelotvornost lijeka Karvea.
English: Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Croatian: U kliničkim ispitivanjima s bolesnicima liječenima lijekom Karvea prijavljene su sljedeće nuspojave: Vrlo često (mogu se javiti u više od 1 na 10 osoba): ako imate povišen krvni tlak i šećernu bolest tipa 2 te bolest bubrega, krvne pretrage mogu pokazati povišene vrijednosti kalija.
English: Each tablet of Karvea 300 mg contains 300 mg irbesartan.
Croatian: Jedna Karvea 300 mg tableta sadrži 300 mg irbesartana.
English: Diuretics and other antihypertensive agents: other antihypertensive agents may increase the hypotensive effects of irbesartan; however Karvea has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Croatian: Karvea se, međutim, pokazala sigurnom za primjenu s ostalim antihipertenzivnim lijekovima poput beta blokatora, dugodjelujućih blokatora kalcijevih kanala i tiazida.
English: Karvea 75 mg film-coated tablets irbesartan
Croatian: Karvea 75 mg filmom obložene tablete irbesartan
English: Karvea 300 mg tablets irbesartan
Croatian: Karvea 300 mg tablete
English:  The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, and poloxamer 188.
Croatian: Drugi sastojci su mikrokristalična celuloza, umrežena karmelozanatrij, laktoza hidrat, magnezijev stearat, koloidni hidratizirani silicijev dioksid, prethodno geliran kukuruzni škrob i poloksamer 188. Vidjeti dio 2., „Karvea sadrži laktozu“
English: How to store Karvea
Croatian: Kako čuvati lijek Karvea
English: NAME OF THE MEDICINAL PRODUCT Karvea 75 mg tablets irbesartan STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 75 mg LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA NAZIV LIJEKA Karvea 75 mg tablete irbesartan NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 75 mg irbesartana POPIS POMOĆNIH TVARI
English: Do not take Karvea  if you are allergic to irbesartan or any other ingredients of this medicine (listed in section 6)  if you are more than 3 months pregnant.
Croatian: Nemojte uzimati lijek Karvea ako ste alergični na irbesartan ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ako ste trudni više od 3 mjeseca (također se preporučuje izbjegavati Karvea i u ranoj trudnoćividjeti dio o trudnoći) ako imate šećernu bolest ili oštećenu bubrežnu funkciju i liječite se lijekom za snižavanje krvnog tlaka koji sadrži aliskiren
English: Karvea 150 mg film-coated tablets irbesartan
Croatian: Karvea 150 mg filmom obložene tablete irbesartan
English: Package leaflet: Information for the user Karvea 75 mg tablets irbesartan
Croatian: Uputa o lijeku: Informacija za korisnika Karvea 75 mg tablete irbesartan
English: NAME OF THE MEDICINAL PRODUCT Karvea 300 mg tablets irbesartan STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 300 mg LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA NAZIV LIJEKA Karvea 300 mg tablete irbesartan NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 300 mg irbesartana POPIS POMOĆNIH TVARI
English: NAME OF THE MEDICINAL PRODUCT Karvea 150 mg tablets irbesartan STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 150 mg LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA NAZIV LIJEKA Karvea 150 mg tablete irbesartan NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 150 mg irbesartana POPIS POMOĆNIH TVARI
English: Karvea 300 mg film-coated tablets irbesartan
Croatian: Karvea 300 mg filmom obložene tablete irbesartan
English: Karvea 75 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Croatian: Karvea 75 mg tablete dostupne su u blister pakiranjima s 14, 28, 56 ili 98 tableta.
English: Package leaflet: Information for the user Karvea 75 mg film-coated tablets irbesartan
Croatian: Uputa o lijeku: Informacija za korisnika Karvea 75 mg filmom obložene tablete irbesartan
English: Karvea 75 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 filmcoated tablets.
Croatian: Karvea 75 mg filmom obložene tablete dostupne su u blister pakiranjima s 14, 28, 30, 56, 84, 90 ili 98 filmom obloženih tableta.
English: Karvea 300 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Croatian: Karvea 300 mg tablete dostupne su u blister pakiranjima s 14, 28, 56 ili 98 tableta.